Essilor Stellest spectacle lenses slow myopia, axial length progression in children
Click Here to Manage Email Alerts
NEW ORLEANS — EssilorLuxottica’s Essilor Stellest lenses slowed myopia progression and axial length increase in children in a 4-year clinical trial, according to data presented at the Association for Research in Vision and Ophthalmology meeting.
Children who wore spectacles with highly aspherical lenslets (HAL) saved more than 1.25 D of myopia over 4 years in the trial, which began in 2018 at the Eye Hospital of Wenzhou Medical University in China, according to a company press release. HAL lenses served as the optical design inspiration for the Essilor Stellest lenses.
Trial results also demonstrated slower progression of myopia and axial length elongation in children wearing HAL lenses compared with a modeled control group wearing single-vision lenses. The HAL lenses also remained effective at slowing myopia and axial length elongation in older children aged 11 to 16 years in the fourth year, the release stated.
“To move the needle further, we will continue to advance myopia research, deliver innovative solutions, build partnerships to strengthen awareness and education, and share insights and expertise at key conferences,” Norbert Gorny, co-chief operating officer at EssilorLuxottica, said in the release.
The announcement of these findings came after publication of 3-year clinical trial results in the American Journal of Ophthalmology, which showed continued myopia control efficacy in children wearing HAL lenses compared with single-vision lenses. The 3-year trial also demonstrated that HAL lenses decreased myopia progression and axial length elongation in children who switched after wearing single-vision lenses for 2 years.
Reference:
Click Here to Manage Email Alerts